Selected article for: "adaptive immune response and CNS central nervous system"

Author: Cheng, Yuting; Skinner, Dominic D.; Lane, Thomas E.
Title: Innate Immune Responses and Viral-Induced Neurologic Disease
  • Cord-id: kevue6gi
  • Document date: 2018_12_20
  • ID: kevue6gi
    Snippet: Multiple sclerosis (MS) is a disease of the central nervous system (CNS) characterized by chronic neuroinflammation, axonal damage, and demyelination. Cellular components of the adaptive immune response are viewed as important in initiating formation of demyelinating lesions in MS patients. This notion is supported by preclinical animal models, genome-wide association studies (GWAS), as well as approved disease modifying therapies (DMTs) that suppress clinical relapse and are designed to impede
    Document: Multiple sclerosis (MS) is a disease of the central nervous system (CNS) characterized by chronic neuroinflammation, axonal damage, and demyelination. Cellular components of the adaptive immune response are viewed as important in initiating formation of demyelinating lesions in MS patients. This notion is supported by preclinical animal models, genome-wide association studies (GWAS), as well as approved disease modifying therapies (DMTs) that suppress clinical relapse and are designed to impede infiltration of activated lymphocytes into the CNS. Nonetheless, emerging evidence demonstrates that the innate immune response e.g., neutrophils can amplify white matter damage through a variety of different mechanisms. Indeed, using a model of coronavirus-induced neurologic disease, we have demonstrated that sustained neutrophil infiltration into the CNS of infected animals correlates with increased demyelination. This brief review highlights recent evidence arguing that targeting the innate immune response may offer new therapeutic avenues for treatment of demyelinating disease including MS.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and adaptive immune response: 1, 2, 3
    • action mechanism and adhesion molecule: 1, 2, 3
    • action mechanism and adoptive transfer: 1
    • activation ifn signal and adaptive immune response: 1
    • acute disease and adapter protein: 1, 2
    • acute disease and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and additional benefit: 1, 2, 3
    • acute disease and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute disease and adoptive transfer: 1, 2, 3, 4, 5, 6, 7
    • acute encephalomyelitis and adoptive transfer: 1, 2
    • adaptive immune response and adhesion molecule: 1, 2, 3